Technical analysis of Caribou Biosciences, Inc. (CRBU): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Caribou Biosciences, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to pioneering genome-edited allogeneic cell therapies. These cutting-edge treatments are engineered to address both hematologic malignancies (blood cancers) and solid tumors, serving patients across the United States and internationally.
Price Performance
| 1 month | -19.87% |
| 3 months | -23.78% |
| Year-to-date | -21.38% |
| 1 year | -27.33% |
| 3 years | -76.21% |
| 5 years | -94.91% |
52-Week Range
| 52-week High | $3.54 |
| 52-week Low | $1.25 |
| Avg Volume (90d) | 1.7M |
Technical Indicators
| SMA 50 | $1.60 |
| SMA 200 | $1.77 |
| Beta | 2.46 |
| 30-day Volatility (annualised) | 53.9% |
| Price vs SMA 50 | -21.8% |
| Price vs SMA 200 | -29.6% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $2.42 | |
| 2025-11 | $1.94 | -19.8% |
| 2025-12 | $1.59 | -18.0% |
| 2026-01 | $1.41 | -11.3% |
| 2026-02 | $1.90 | +34.8% |
| 2026-03 | $1.90 | +0.0% |
| 2026-04 | $1.88 | -1.1% |
| 2026-05 | $2.36 | +25.5% |
| 2026-06 | $1.76 | -25.4% |
| 2026-07 | $1.46 | -17.0% |
| 2026-08 | $1.54 | +5.5% |
| 2026-09 | $1.25 | -18.8% |
Price
| Price | $1.25 |
| Market Cap | $124M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 1.25 |
| EV / EBITDA | -1.50 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.27 |
| Current Ratio | 6.49 |